Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 9.89x is 38% below its estimated 1-year average of 15.91x, near the low end of its estimated 1-year range (7.25x–26.17x).
As of 2026-10-06T19:11:24.694Z.
Calculation as of: 2026-10-06T19:11:24.694Z.
Quote observation: 2026-10-06T19:01:56.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e47236677832b0178bb4e4de0ecbdefb2e069a6eb9feaf5a3a870b06349bdf9c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
9.89x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.40x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
+124.77%
vs the sector median at left
Market Cap
$76.54M
EV/Sales Ratio
0.82x
TTM Avg
0.97x
3Y Avg
1.24x
5Y Avg
3.60x
Market Cap
$77.15M
EV/Sales Ratio
1082.13x
TTM Avg
1504.99x
3Y Avg
1363.48x
5Y Avg
1169.35x
Market Cap
$77.02M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$75.82M
EV/Sales Ratio
0.87x
TTM Avg
0.66x
3Y Avg
2.48x
5Y Avg
6.11x
Market Cap
$77.38M
EV/Sales Ratio
N/A
TTM Avg
412.28x
3Y Avg
264.96x
5Y Avg
234.31x
Market Cap
$79.29M
EV/Sales Ratio
N/A
TTM Avg
5027.01x
3Y Avg
2607.85x
5Y Avg
1729.21x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Citius Oncology, Inc. (CTOR) | $76.65M | 9.89x | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $76.54M | 0.82x | 0.97x | 1.24x | 3.60x |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | 1082.13x | 1504.99x | 1363.48x | 1169.35x |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.02M | N/A | N/A | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $75.82M | 0.87x | 0.66x | 2.48x | 6.11x |
| Outset Medical, Inc. (OM)vs › | $77.30M | 1.25x | 1.34x | 1.69x | 5.72x |
| Hyperfine, Inc. (HYPR)vs › | $75.41M | 2.74x | 6.00x | 3.83x | 57.38x |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $77.38M | N/A | 412.28x | 264.96x | 234.31x |
| vTv Therapeutics Inc. (VTVT)vs › | $79.29M | N/A | 5027.01x | 2607.85x | 1729.21x |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 12.37x |
| 2026-10-02 | 13.53x |
| 2026-10-01 | 13.99x |
| 2026-09-30 | 14.44x |
| 2026-09-29 | 15.05x |
| 2026-09-28 | 14.75x |
| 2026-09-25 | 15.05x |
| 2026-09-24 | 15.05x |
| 2026-09-23 | 14.44x |
| 2026-09-22 | 15.35x |
| 2026-09-21 | 15.05x |
| 2026-09-18 | 16.42x |
| 2026-09-17 | 14.59x |
| 2026-09-16 | 13.59x |
| 2026-09-15 | 12.10x |
| 2026-09-14 | 13.38x |
| 2026-09-11 | 13.04x |
| 2026-09-10 | 12.92x |
| 2026-09-09 | 13.38x |
| 2026-09-08 | 13.21x |
| 2026-09-04 | 12.16x |
| 2026-09-03 | 11.14x |
| 2026-09-02 | 10.91x |
| 2026-09-01 | 10.49x |
| 2026-08-31 | 10.69x |
| 2026-08-28 | 10.88x |
| 2026-08-27 | 11.11x |
| 2026-08-26 | 11.06x |
| 2026-08-25 | 11.41x |
| 2026-08-24 | 10.49x |
| 2026-08-21 | 10.40x |
| 2026-08-20 | 10.63x |
| 2026-08-19 | 10.53x |
| 2026-08-18 | 9.78x |
| 2026-08-17 | 10.34x |
| 2026-08-14 | 12.92x |
| 2026-08-13 | 11.66x |
| 2026-08-12 | 11.43x |
| 2026-08-11 | 10.19x |
| 2026-08-10 | 10.30x |
| 2026-08-07 | 10.54x |
| 2026-08-06 | 10.65x |
| 2026-08-05 | 11.03x |
| 2026-08-04 | 9.13x |
| 2026-08-03 | 8.60x |
| 2026-07-31 | 8.10x |
| 2026-07-30 | 7.82x |
| 2026-07-29 | 7.25x |
| 2026-07-28 | 7.33x |
| 2026-07-27 | 7.55x |
| 2026-07-24 | 7.64x |
| 2026-07-23 | 7.89x |
| 2026-07-22 | 7.81x |
| 2026-07-21 | 7.76x |
| 2026-07-20 | 7.76x |
| 2026-07-17 | 9.57x |
| 2026-07-16 | 9.46x |
| 2026-07-15 | 9.57x |
| 2026-07-14 | 8.98x |
| 2026-07-13 | 9.81x |
| 2026-07-10 | 9.60x |
| 2026-07-09 | 10.06x |
| 2026-07-08 | 10.19x |
| 2026-07-07 | 9.89x |
| 2026-07-06 | 9.87x |
| 2026-07-02 | 9.44x |
| 2026-07-01 | 9.80x |
| 2026-06-30 | 11.80x |
| 2026-06-29 | 12.53x |
| 2026-06-26 | 11.26x |
| 2026-06-25 | 11.97x |
| 2026-06-24 | 12.43x |
| 2026-06-23 | 12.42x |
| 2026-06-22 | 12.83x |
| 2026-06-18 | 12.15x |
| 2026-06-17 | 11.98x |
| 2026-06-16 | 11.98x |
| 2026-06-15 | 12.33x |
| 2026-06-12 | 12.04x |
| 2026-06-11 | 12.55x |
| 2026-06-10 | 12.45x |
| 2026-06-09 | 13.04x |
| 2026-06-08 | 14.47x |
| 2026-06-05 | 14.11x |
| 2026-06-04 | 14.40x |
| 2026-06-03 | 14.10x |
| 2026-06-02 | 14.16x |
| 2026-06-01 | 14.33x |
| 2026-05-29 | 14.43x |
| 2026-05-28 | 14.59x |
| 2026-05-27 | 16.05x |
| 2026-05-26 | 15.54x |
| 2026-05-22 | 15.18x |
| 2026-05-21 | 14.99x |
| 2026-05-20 | 14.93x |
| 2026-05-19 | 14.97x |
| 2026-05-18 | 14.98x |
| 2026-05-15 | 20.48x |
| 2026-05-14 | 20.94x |
| 2026-05-13 | 21.00x |
| 2026-05-12 | 19.14x |
| 2026-05-11 | 19.16x |
| 2026-05-08 | 19.22x |
| 2026-05-07 | 19.09x |
| 2026-05-06 | 19.28x |
| 2026-05-05 | 20.33x |
| 2026-05-04 | 19.52x |
| 2026-05-01 | 20.07x |
| 2026-04-30 | 18.63x |
| 2026-04-29 | 18.18x |
| 2026-04-28 | 18.34x |
| 2026-04-27 | 18.48x |
| 2026-04-24 | 18.56x |
| 2026-04-23 | 20.80x |
| 2026-04-22 | 19.95x |
| 2026-04-21 | 19.07x |
| 2026-04-20 | 19.60x |
| 2026-04-17 | 18.58x |
| 2026-04-16 | 16.97x |
| 2026-04-15 | 17.52x |
| 2026-04-14 | 16.41x |
| 2026-04-13 | 14.19x |
| 2026-04-10 | 14.08x |
| 2026-04-09 | 13.75x |
| 2026-04-08 | 13.35x |
| 2026-04-07 | 13.84x |
| 2026-04-06 | 14.35x |
| 2026-04-02 | 14.70x |
| 2026-04-01 | 13.49x |
| 2026-03-31 | 12.86x |
| 2026-03-30 | 10.05x |
| 2026-03-27 | 10.46x |
| 2026-03-26 | 11.11x |
| 2026-03-25 | 11.93x |
| 2026-03-24 | 12.03x |
| 2026-03-23 | 12.98x |
| 2026-03-20 | 13.37x |
| 2026-03-19 | 14.43x |
| 2026-03-18 | 14.24x |
| 2026-03-17 | 16.09x |
| 2026-03-16 | 16.98x |
| 2026-03-13 | 17.13x |
| 2026-03-12 | 19.29x |
| 2026-03-11 | 19.80x |
| 2026-03-10 | 21.29x |
| 2026-03-09 | 21.51x |
| 2026-03-06 | 21.73x |
| 2026-03-05 | 22.84x |
| 2026-03-04 | 23.29x |
| 2026-03-03 | 22.62x |
| 2026-03-02 | 23.06x |
| 2026-02-27 | 23.95x |
| 2026-02-26 | 23.29x |
| 2026-02-25 | 23.73x |
| 2026-02-24 | 23.73x |
| 2026-02-23 | 24.39x |
| 2026-02-20 | 24.84x |
| 2026-02-19 | 25.95x |
| 2026-02-18 | 25.06x |
| 2026-02-17 | 25.28x |
| 2026-02-13 | 26.17x |
| 2026-02-12 | 25.28x |
| 2026-02-11 | 24.17x |
| 2026-02-10 | 24.17x |
| 2026-02-09 | 23.73x |
| 2026-02-06 | 24.17x |
| 2026-02-05 | 23.73x |
| 2026-02-04 | 24.62x |
| 2026-02-03 | 23.73x |
| 2026-02-02 | 23.06x |
| 2026-01-30 | 22.62x |
| 2026-01-29 | 23.51x |
| 2026-01-28 | 23.29x |
| 2026-01-27 | 23.51x |
| 2026-01-26 | 23.51x |
| 2026-01-23 | 24.17x |
| 2026-01-22 | 23.95x |
| 2026-01-21 | 24.62x |
| 2026-01-20 | 22.40x |
| 2026-01-16 | 22.40x |
| 2026-01-15 | 23.06x |
| 2026-01-14 | 23.51x |
| 2026-01-13 | 23.29x |
| 2026-01-12 | 22.84x |
| 2026-01-09 | 23.29x |
| 2026-01-08 | 24.17x |
| 2026-01-07 | 24.62x |
| 2026-01-06 | 25.72x |
| 2026-01-05 | 24.62x |
| 2026-01-02 | 23.06x |
